NeuroRx, Inc. and Relief Therapeutics Holdings AG have announced that RLF-100 (aviptadil) showed rapid recovery from respiratory failure in critically ill patients with COVID-19 in clinical trials. Independent research has also demonstrated that aviptadil blocked replication of the SARS coronavirus in human lung cells and monocytes. RLF-100 has been granted Fast Track designation by the FDA. Yourway is the market leader for clinical supply shipments. Whether your shipments are small or large molecule, high or low volume, Yourway has the expertise and capabilities to ensure your drug product reaches its destination safely and efficiently.